The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
Right TT.. NCM is not just about Hav and they have their own shareholder commitments too. If they want to play games, they would rather subdue the Hav results rather than not releasing the report itself and making it balantly obvious to the market. I think SB and NCM team would be lot smarter than this.
James i agree next quarterly is on 28 Apr and last was on 28 Jan - its on their website. So there are 13 weeks between the two and all i am saying is that interim could be after 7 weeks rather than 6 weeks since we had half year results in mid Feb.
https://www.newcrest.com/investor-centre/key-dates
I had a msked this question yesterday but no response. we have 13 weeks between 2 quarterlt updates, so interim could be at either 6 weeks or 7 weeks gap in between. Considering there was half year results in between interim might well be next week.
Let's not speculate too much
Where RNS will be published any moment.
https://www2.asx.com.au/markets/trade-our-cash-market/todays-announcements
https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=02479789
Sneaky - I mis-read the Nov RNS. I have been here for a while (almost 8 years) but it was in my bottom drawer as I was sitting on 95% loss at once point. Hence I am not up-to-date on activities here, hence seeked clarification. Thanks
sorry I mis-read the RNS it is $2.2m by end of 2022 but first payment of end of 2021. Is this what we are waiting for or are we expecting the outcome of the due diligence by Theomerx to be completed by 31 Dec?
GH was delivering new unexpected highs all the ways and SD is delivering new unexpected lows all the way since taken over. I never expected this to go below 20p on its worst day..! Well made a mistake of buying 110k shares on the offer last week.. mistake for short term hopefully...!
GL